Advanced Medical Solutions Group (AMS) Fair Value & Analysis
Healthcare · GB · Market cap 473M GBX
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 5 days ago
Fair value updated Jun 24, 2026 — revised from £1.18 to £1.02 (−13.6%) since Jun 23, 2026. Share price +27.9% over the past month.
Price vs Fair Value (12 months)
12‑month range £1.66 – £2.45 · fair‑value band £0.8200 – £1.42 · the £2.45 price screens above the £1.02 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Advanced Medical Solutions Group (AMS) currently trades at £2.45, while our model-based Fair Value estimate is £1.02 — implying the stock looks roughly 58.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Advanced Medical Solutions Group generated revenue of £229M at a net margin of 4.4%. Revenue grew 7.9% year over year. It earns a return on equity of 4.0%. Net debt stands at £63.5M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and ActivHeal brand names. The company provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Advanced Medical Solutions Group reported revenue of £229M in FY2025 versus £109M in FY2021, a compound +20.5%/yr. Reported net income was £10.0M in FY2025, compounding −13.1%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.95 | $182.39 | -55% |
| EssilorLuxottica Société anonyme ESLOF | $190.25 | $125.65 | -34% |
| HOYA Corporation HOCPY | $168.16 | $96.16 | -43% |
| Medline Inc MDLN | $33.61 | $31.78 | -5% |
| Becton, Dickinson and Company BDX | $149.56 | $117.04 | -22% |
| Alcon Inc ALC | $66.11 | $36.99 | -44% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Advanced Medical Solutions Group (AMS) undervalued?
What is the fair value of AMS?
What is the quality score of AMS?
What is the revenue of Advanced Medical Solutions Group (AMS)?
What is the net profit margin of AMS?
Does Advanced Medical Solutions Group pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.